Quality and Safety Risk Detection in Healthcare
A rise in incidents or adverse outcomes may indicate a quality problem. However, it may also reflect higher activity, a more complex patient population, changed coding or stronger reporting. A decline can be equally misleading when staff stop reporting near misses.
Healthcare risk detection must separate these explanations before management intervenes. Marketways combines outcome measures, exposure, case mix, process evidence and incident review to identify patterns that warrant qualified attention. The analysis directs investigation; it does not convert a statistical signal into a clinical conclusion.
Define the harm and the available response
A broad objective such as improving patient safety cannot determine what data to collect or which signal requires escalation. The organisation must define the event, affected population, time horizon and feasible intervention.
Marketways begins with the management and clinical decision. We identify what the organisation aims to prevent, how the event is observed, who can investigate and what action remains possible. A signal has limited value if it arrives after the organisation can protect the patient or correct the underlying process.
This definition also establishes the cost of error. A missed warning and an unnecessary review do not carry equal consequences for every harm. The detection threshold must reflect that difference.
Compare outcomes with the population at risk
Raw incident counts rise when a service treats more patients, performs more procedures or serves a population with greater clinical complexity. Comparing counts across time or locations can therefore misidentify improvement or deterioration.
Marketways defines the relevant denominator and exposure. Depending on the event, this may be admissions, procedures, device days, medication administrations or time at risk. We then assess whether severity, comorbidity, pathway and other patient characteristics require risk adjustment.
Risk adjustment does not excuse poor performance. It creates a fairer starting point for investigation. The organisation still needs to examine whether care, staffing or process explains the remaining difference.
Separate reporting behaviour from the underlying condition
Incident reports reveal what people noticed and chose to record. They do not provide a complete census of harm. Staff may report more after a safety campaign and less when they expect blame or see no response.
Marketways analyses report frequency with severity, content, reporter mix, timing and follow-through. We compare voluntary reports with outcomes, complaints, audits and other sources where appropriate. This helps distinguish a change in reporting behaviour from a change in the clinical or operational condition.
The distinction protects learning. A simple count can punish a team that reports hazards openly while making a quiet but unsafe environment appear successful.
Test whether the measure itself changed
A new coding rule, electronic-record field, data extraction or event definition can create an apparent shift without any change in care. Missing data can also vary by ward, service or period.
Marketways reviews the measure lineage before interpreting the pattern. We identify changes in definitions, inclusion rules, coding practice, system configuration and data completeness. Where possible, we reconstruct the measure consistently across the comparison period.
If the historical data cannot support a valid comparison, the analysis states that limitation. Management should not demand a precise trend from a measure whose meaning changed.
Distinguish expected variation from a material signal
Healthcare measures vary even when the underlying process remains stable. Reacting to every increase can create repeated investigations, unstable procedures and alert fatigue.
Marketways uses run charts, statistical process control, risk-adjusted comparisons and suitable anomaly methods to identify changes that are unlikely to reflect ordinary variation. The method depends on event frequency, denominator, case mix and the form of the data.
A statistical signal shows that the observed pattern deserves attention. It does not establish the cause. The analysis must preserve uncertainty and provide the cases, definitions and contributing measures required for review.
Convert the signal into a qualified investigation
Clinical and safety teams need more than a red indicator. They need to know which patients, pathways, times and operating conditions contributed to the signal.
Marketways prepares an investigation case that links the measure with relevant records, staffing, workload, process changes and prior incidents. We identify plausible explanations and the additional evidence needed to distinguish them.
Qualified reviewers determine the clinical meaning and appropriate response. The analytical system supports their attention; it does not assign negligence, clinical fault or disciplinary responsibility.
Examine rare severe harm through mechanisms and barriers
Rare events provide too little frequency for a trend alone to offer dependable warning. The absence of recent harm also does not prove that protective barriers remain effective.
Marketways supplements observed events with known cases, near misses, barrier measures and expert-designed scenarios. We examine the conditions that allow a hazard to progress, the control that should interrupt it and the evidence that the control functioned.
This mechanism-based view can reveal a weakening defence before another severe event occurs. It also prevents management from treating a period without harm as proof that the risk disappeared.
Evaluate AI detection against realistic failure conditions
An AI model may combine many weak signals that would be difficult to monitor manually. However, a high retrospective score does not establish that the model will remain useful when coding, workflow or patient mix changes.
Marketways evaluates missed events, false alerts, calibration, subgroup performance, warning lead time and stability across operating conditions. Tests include missing fields, delayed data, definition changes and cases that resemble risk but require a different response.
The alert threshold must match review capacity. A model that identifies every possible concern but overwhelms the safety team can delay attention to the cases that matter most.
Use Agentic AI to assemble evidence, not assign blame
An Agentic AI workflow can retrieve authorised records, construct a timeline, identify missing evidence and route the case to the responsible safety or clinical team. It can also track whether review, escalation and corrective action occur.
Marketways limits the workflow's sources, tools and declarations. The agent must preserve patient identity, cite its evidence and expose contradictions. It cannot determine negligence, make a clinical judgement or initiate disciplinary action.
This boundary keeps accountability with qualified people while reducing the administrative effort required to investigate a valid signal.
Test whether corrective action changes the risk
Closing an action item records completion of an administrative task. It does not prove that the underlying hazard or outcome changed.
Marketways defines evidence for the intended effect. We may track recurrence, time to control, barrier reliability, review yield, missed signals, false alerts and the relevant patient or operating outcome. Statistical process control can show whether the measure changed after implementation and whether the change persisted.
The review also checks for displacement. An intervention may reduce one recorded incident while moving the problem to another pathway or discouraging reports. Learning requires evidence about the complete risk, not merely completion of the response plan.
A rise in medication incidents illustrates the diagnosis
Suppose a hospital records more medication incidents after introducing barcode administration and a campaign that encourages near-miss reporting. The increase could indicate worsening safety, better detection, a workflow problem created by the new system or several effects at once.
Marketways would relate incidents to medication administrations, severity, ward, shift, patient complexity and reporting source. We would examine whether the increase began with the technology change, whether harm rose with reports and whether staff bypassed a control under specific operating conditions.
The investigation might find that near-miss reporting improved while one ward experienced a genuine scanning failure during peak workload. Management could preserve the reporting culture and correct the specific control instead of imposing a broad response based on the total count.
How Marketways designs healthcare risk detection
Marketways combines Risk Detection, AI Governance and Model Risk and Anomaly and Novelty Detection. We define the harm and intervention, align outcomes with exposure and case mix, examine reporting behaviour and connect statistical signals with qualified review and corrective-action evidence.
The resulting system tells management which pattern warrants investigation, what evidence supports it and how the organisation will determine whether its response reduced the underlying risk.